BIO-Europe Spring 2015: Interview with Kunihiko Suzuki, Medinet
Immunotherapy promises to transform healthcare, but is slowed by limited access to affordable materials, know-how and development facilities. Kunihiko Suzuki of Medinet discusses the ways in which his company is helping to break this bottleneck for companies worldwide.
Find more videos and articles at http://www.partnering360.com/insight.
For more information on BIO-Europe Spring, visit our webpage: http://www.ebdgroup.com/bes/index.php